908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates

Core Insights - 908 Devices Inc. reported a quarterly loss of $0.23 per share, better than the Zacks Consensus Estimate of a loss of $0.29, representing an earnings surprise of 20.69% [1] - The company posted revenues of $16.77 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 8.13%, but showing an increase from $14.3 million year-over-year [2] - The stock has underperformed significantly, losing about 67.7% since the beginning of the year compared to the S&P 500's gain of 25.8% [3] Financial Performance - Over the last four quarters, 908 Devices has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.22 on revenues of $21.43 million, and for the current fiscal year, it is -$1.22 on revenues of $63.74 million [7] Market Outlook - The estimate revisions trend for 908 Devices is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] - The Medical - Instruments industry, to which 908 Devices belongs, is currently in the top 27% of Zacks industries, suggesting a favorable industry outlook [8]